Pharmaceuticals

Therapeutic BCG Vaccines Market 2025–2029: Strategic Opportunities and Growth Insights

December 3, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the therapeutic bcg vaccines market from 2025–2034 with trusted insights from The Business Research Company

What Are The Market Size Estimates For The Therapeutic BCG Vaccines Market Now And By 2029?

The therapeutic bcg vaccines market size has observed consistent expansion in recent years. This market is set to increase from $56.47 billion in 2024 to $59.09 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.6%. Key contributors to this historical growth include government initiatives for tuberculosis control, the role of immune system modulation, extensive global immunization programs, its application in the treatment of bladder cancer, enhanced investments in vaccine manufacturing, and the emergence of drug-resistant tuberculosis strains.

The therapeutic bcg vaccines market is projected to experience substantial expansion in the coming years, with its size forecast to reach $75.46 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.3%. This anticipated growth during the forecast period is primarily driven by factors such as the broadening of its applications to other indications, intensified research in immunotherapy, global initiatives addressing emerging infectious diseases, supportive regulatory environments for vaccine development, and a concentrated focus on tuberculosis elimination. Furthermore, significant trends expected during this period include advancements in vaccine technology, optimization of supply chains, market consolidation and strategic partnerships, increased patient education and awareness, the development of alternative delivery methods, and the adoption of personalized medicine approaches.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9178&type=smp

Which Long-Term Drivers Are Expected To Sustain The Therapeutic BCG Vaccines Market?

The global increase in tuberculosis (TB) incidents is expected to drive the expansion of the therapeutic BCG vaccine market moving forward. TB, an infectious and potentially hazardous disease, predominantly affects the lungs and spreads through airborne bacterial droplets from coughing or sneezing individuals. BCG vaccines stimulate the immune system to combat infection without causing TB, as they contain weakened germs. This vaccine reliably safeguards against severe forms of TB, including adolescent TB meningitis, thus leading to increased adoption of therapeutic BCG vaccines due to their protective role against tuberculosis. A concrete example of this trend is detailed in a February 2024 report by the UK Health Security Agency, a UK-based government body, which revealed that tuberculosis (TB) cases in England rose by 10.7% in 2023, reaching 4,850 reported cases compared to 4,380 in 2022. Consequently, the rising number of tuberculosis (TB) cases worldwide is a primary catalyst for the growth of the therapeutic BCG vaccine market.

How Is The Therapeutic BCG Vaccines Market Classified By Different Segments?

The therapeutic bcg vaccines market covered in this report is segmented –

1) By Type: Therapy BCG, Immune BCG

2) By Demographics: Pediatrics, Adults

3) By End Use: Hospitals, Clinics, Other End Users

Subsegments:

1) By Therapy BCG: Intravesical BCG, Injectable BCG

2) By Immune BCG: BCG For Immune Enhancement, BCG For Allergy Treatment

What Current And Upcoming Trends Are Shaping The Therapeutic BCG Vaccines Market?

Strategic collaborations have emerged as a significant and increasingly favored trend within the therapeutic BCG vaccine market. Major companies operating in the therapeutic BCG vaccine market are concentrating on forming alliances with other key players to sustain their market position. For instance, in May 2024, ImmunityBio, a US-based biotechnology company, entered into a partnership with Serum Institute of India, an India-based biotechnology and biopharmaceuticals company, to secure a supply of the Bacillus Calmette-Guerin (BCG) vaccine for all cancer types. This collaboration focuses on producing both the standard BCG (sBCG), approved for use outside the US, and a next-generation recombinant BCG (iBCG) currently undergoing tests. The iBCG is intended for co-administration with ImmunityBio’s ANKTIVA (nogapendekin alfa inbakicept-PMLN) for approved as well as additional future indications, subject to regulatory approvals.

Who Are The Primary Market Leaders In The Therapeutic BCG Vaccines Market?

Major companies operating in the therapeutic bcg vaccines market include Merck & Co Inc., Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute of India Pvt. Ltd., InterVax Ltd., GreenSignal Bio Pharma Limited, Statens Serum Institute, AJ Vaccines, Bul Bio-National Center of Infectious and Parasitic Diseases Ltd, Biomed Lublin S.A., Microgen, Taj Pharma Ltd., PT Bio Farma, Torlak Institute of Virology, Bacille Bilie Calmette-Guerin Laboratory, China Biotechnology Co Ltd., Bharat Biotech International Ltd., Biological E. Limited, Shanghai Institute of Biological Products Co. Ltd., Cipla Limited, Instituto Butantan

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/therapeutic-bcg-vaccines-global-market-report

Which Regional Markets Are Emerging As Key Centers For The Therapeutic BCG Vaccines Market?

Asia-Pacific was the largest region in the therapeutic BCG vaccines market in 2024. The regions covered in the therapeutic bcg vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=9178&type=smp

Browse Through More Reports Similar to the Global Therapeutic BCG Vaccines Market 2025, By The Business Research Company

Wound Care Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/wound-care-devices-global-market-report

Benign Prostatic Hyperplasia Bph Treatment Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/benign-prostatic-hyperplasia-bph-treatment-devices-and-equipment-global-market-report

Pain Management Devices And Therapies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pain-management-devices-and-therapies-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795